✦ LIBER ✦

Safety of Bevacizumab Therapy in Subjects with Brain Metastases due to Non–Small-Cell Lung Cancer (NSCLC)

✍ Scribed by J. Hainsworth; W. Akerley; Y. Oh; D.K. Strickland; S. Royer-Joo; X. Zhou; Q. Xia; J. Huang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acceptable Safety of Bevacizumab Therapy

✍ Wallace Akerley; Corey Langer; Yun Oh; D.K. Strickland; Margaret Kolb; Qi Xia; Y 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 62 KB

Efficacy and safety of bevacizumab in ac

✍ Kevin C. De Braganca; Yelena Y. Janjigian; Christopher G. Azzoli; Mark G. Kris; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 208 KB

324 Treatment of brain metastases in pat

✍ C̆oupková, H.; C̆oupek, P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Erlotinib therapy in a patient with non-

✍ Giuseppe Altavilla; Carmela Arrigo; Maria Carmela Santarpia; Giuseppe Galletti; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

High local recurrence and brain metastas

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Safety of Bevacizumab Treatment in Non–S

✍ J. Skillings; F. LaFleur; N. Leighl; J. Bennouna; H.-P. Kuo; B. Szima; M. Gottfr 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 450 KB